TAK-639 is a promising drug in the biomedical industry. Extensive research has shown that TAK-639 is effective in treating a range of autoimmune diseases, including rheumatoid arthritis and psoriasis.
CAT# | R2003 |
M.F/Formula | C65H110ClN13O13 |
M.W/Mr. | 1317.10 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Tetracosactide (also known as Tetracosactide) is a synthetic peptide that is identical to the 24-amino acid segm ...
Iron chelating agent is a new type of iron-removing treatment based on the combination of directional and in viv ...
Brief information of orexin peptide The past several years have provided important insights into the physiological significan ...
P11 (HSDVHK) is a novel peptide ligand containing a PDZ-binding motif (Ser-Asp-Val) with high affinity to integr ...
JIP1, a member of the JIPs family, was first discovered to promote JNK activation by combining multiple componen ...